Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2023 Publisher: Sandoz Limited, Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL, United Kingdom
Matoride XL 18 mg prolonged-release tablets.
| Pharmaceutical Form |
|---|
|
Prolonged-release tablet. Light yellow film-coated tablet of round shape (diameter 8 mm) with a delivery orifice (visible round small hole) on one side. |
Each prolonged-release tablet contains 18 mg of methylphenidate hydrochloride.
Excipient(s) with known effect: Each prolonged-release tablet contains 5.99 mg of lactose (as monohydrate) and 0.34 mmol (7.8 mg) of sodium.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Methylphenidate |
Methylphenidate HCl is a mild central nervous system (CNS) stimulant. The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known. Methylphenidate is thought to block the reuptake of noradrenaline and dopamine into the presynaptic neurone and increase the release of these monoamines into the extraneuronal space. |
| List of Excipients |
|---|
|
Drug layer: Polyethylene oxide Push layer: Polyethylene oxide Membrane layer: Cellulose acetate Drug coat: Hypromellose Film coat: film coating mixture consisting of: Lactose monohydrate |
The prolonged-release tablets are packed in high-density polyethylene (HDPE) bottles with a child-resistant polypropylene closure (PP screw cap) with drying plug.
Pack size:
28 or 30 prolonged-release tablets or
Multipacks: 60 (2x30) or 90 (3x30) prolonged-release tablets
Not all pack sizes may be marketed.
Sandoz Limited, Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL, United Kingdom
PL 04416/1346
Date of first authorisation: 08 November 2013
Date of latest renewal: 23 July 2016
| Drug | Countries | |
|---|---|---|
| MATORIDE | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
